Our podcast series “Deep Dive” delivers clear, accessible explanations of cutting-edge organoid research, turning complex discoveries into bite-size science for anyone curious about the future of biology. Each episode is narrated using AI-generated voiceover for consistency and clarity, but every script undergoes stringent review and refinement by our human scientific team to ensure accuracy, rigor, and nuance. Whether you’re an organoid enthusiast, a researcher, or simply fascinated by modern biomedicine, we break down the latest papers and breakthroughs to help you stay ahead in this rapidly evolving field.
Featuring leading research on patient-derived organoids and their growing power to transform drug development and personalise medical care
This episode examines how stepwise CRISPR modification of key colorectal cancer drivers in human intestinal organoids recapitulates tumour progression, from growth-factor–independent expansion to aneuploidy and invasive carcinoma in vivo
In this episode, we explore how advanced intestinal organoids are transforming drug development by more accurately predicting absorption, metabolism, and gut toxicity while reducing reliance on animal models.
We offer a comprehensive range of services designed to accelerate drug discovery and development. Our portfolio includes drug screening, custom model and assay development, and running co-clinical trials in organoids.
